GlaxoSmithKline (GSK) has been ranked number one on Fortune’s 2016 “Change the World” list of firms performing well by doing good, the British pharmaceutical company’s Japanese subsidiary revealed in a press release on 29 August. Last year, GSK ranked 6th in the same list.
A number of the firm’s initiatives contributed to the improved ranking, said GSK Japan President Philippe Fauchet OBE, who also serves on the British Chamber of Commerce in Japan Executive Committee. Among them were GSK’s research and development projects, its vaccine candidates for Ebola and malaria, and initiatives in developing countries to improve access to the firm’s medicines and strengthen those countries’ healthcare systems.
The “Change the World” list was first issued in 2015.